SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-23-000020
Filing Date
2023-05-09
Accepted
2023-05-09 16:53:10
Documents
109
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20230331.htm   iXBRL 10-Q 1929740
2 EX-10.1 amrx-2023033110xqexx101.htm EX-10.1 10406
3 EX-10.2 amrx-2023033110xqexx102.htm EX-10.2 12613
4 EX-10.3 amrx-2023033110xqexx103.htm EX-10.3 10497
5 EX-31.1 amrx-2023033110xqexx311.htm EX-31.1 10449
6 EX-31.2 amrx-2023033110xqexx312.htm EX-31.2 10366
7 EX-31.3 amrx-2023033110xqexx313.htm EX-31.3 10523
8 EX-32.1 amrx-2023033110xqexx321.htm EX-32.1 5719
9 EX-32.2 amrx-2023033110xqexx322.htm EX-32.2 5665
10 EX-32.3 amrx-2023033110xqexx323.htm EX-32.3 5754
  Complete submission text file 0001723128-23-000020.txt   10416443

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20230331.xsd EX-101.SCH 88820
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20230331_cal.xml EX-101.CAL 94644
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20230331_def.xml EX-101.DEF 407697
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20230331_lab.xml EX-101.LAB 854041
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20230331_pre.xml EX-101.PRE 576413
103 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20230331_htm.xml XML 1896441
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 23903025
SIC: 2834 Pharmaceutical Preparations